Search
for
Sort by
Research 181–210 of 518
- Efficacy of tofacitinib in treatment of alopecia universalis in two patients
- Exploring the Drug Repurposing Versatility of Valproic Acid as a Multifunctional Regulator of Innate and Adaptive Immune Cells
- Sterol Intermediates of Cholesterol Biosynthesis Inhibit Hair Growth and Trigger an Innate Immune Response in Cicatricial Alopecia
- Rebound effect associated with JAK inhibitor use in the treatment of alopecia areata
- Recalcitrant alopecia areata responsive to leflunomide and anthralin—Potentially undiscovered JAK/STAT inhibitors?
- Comparative Efficacy and Safety of Janus Kinase Inhibitors Used in Alopecia Areata: A Systematic Review and Meta-analysis
- Sublingual tofacitinib for alopecia areata: a roll‐over pilot clinical trial and analysis of pharmacokinetics
- Novel therapies for alopecia areata: The era of rational drug development
- 1310 Anti-aging effects of retinoid hydroxypinacolone retinoate on skin models
- Oxidative stress and alopecia areata
- JAK-inhibitors in the therapy of comorbid diseases – atopic dermatitis and alopecia areata: literature review and experience of clinical practice
- Increase in IL-15 levels in patients with alopecia areata
- Current and future pharmacotherapy for alopecia areata
- Current Trends and Emerging Paradigms in the Treatment of Alopecia Areata
- Clinical Perspectives on Alopecia: From Hair Follicle Biology to Advanced Therapies
- Evidence Synthesis Gone Awry: The Perils of Aggregating Ineffective or Unsafe Doses in Alopecia Areata Reviews
- Comparative safety profiles of baricitinib and tofacitinib in the treatment of adult alopecia areata: a pharmacovigilance study based on the FAERS database
- Nanotecnología en Tricología: Avances Terapéuticos y Perspectivas Futuras en el Tratamiento de las Alopecias
- Case Report: Successful treatment of pediatric alopecia universalis with ritlecitinib after failure of baricitinib
- Dermatologic Comorbidities Associated with Atopic Dermatitis Towards a Shared Therapeutical Approach: A Narrative Review
- Impacto del desequilibrio del microbioma del cuero cabelludo en la severidad de la alopecia areata, marcadores inflamatorios y cambios post-tratamiento
- Elevation of circulating DNAs of disease-associated cytokines in serum cell-free DNA from patients with alopecia areata
- Effect of Topical Gel Administration of Secretome Hypoxia Mesenchymal Stem Cells (SH-MSCs) on IL-10 and TNF- α Gene Expression (In Vivo Experimental Study in Male Rats of Wistar Strains Model of Fluconazole-Induced Alopecia)
- AP-2α/AP-2β transcription factors are key regulators of epidermal homeostasis
- 1314 Advanced age impairs self-renewal and biases fate choice of hair follicle dermal stem cells
- 1315 An Integrated model of alopecia areata biomarkers highlights both Th1/Th2 upregulation, with stronger correlations between Th2 activation and disease severity
- 1312 Nrf2 activation enhances the healing of cutaneous wounds through the activation of hair follicle stem cells
- 1311 Efficacy of topical tofacitinib in promoting hair growth in non-scarring alopecia
- British Society for Dermatopathology
- Janus Kinase Inhibitors in the Treatment of Alopecia Areata